CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
Open Access
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 29 (8) , 2355-2370.e6
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of War (W81XWH-12-1-0062, W81XWH-15-1-0659)
- American Cancer Society (PF-16-142-01-TBE)
- National Cancer Institute (U01 CA176058)
- Pediatric Cancer Foundation
- Novartis
- National Institutes of Health (K08 CA188615)
This publication has 59 references indexed in Scilit:
- Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc UpregulationPLOS ONE, 2013
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- The mutational landscape of lethal castration-resistant prostate cancerNature, 2012
- A public genome-scale lentiviral expression library of human ORFsNature Methods, 2011
- Integrative genomics viewerNature Biotechnology, 2011
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiationNature Biotechnology, 2010
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate CancerCell, 2009
- GenePattern 2.0Nature Genetics, 2006